Department of Civil and Environmental Engineering, Stanford University, Stanford, California, USA.
mSphere. 2024 Nov 21;9(11):e0064524. doi: 10.1128/msphere.00645-24. Epub 2024 Oct 30.
Wastewater-based epidemiology, which seeks to assess disease occurrence in communities through measurements of infectious disease biomarkers in wastewater, may represent a valuable tool for understanding the occurrence of hepatitis A infections in communities. In this study, we measured concentrations of (HAV) RNA, in samples from 191 wastewater treatment plants spanning 40 US states and the District of Columbia from September 2023 to June 2024 and compared the measurements with traditional measures of disease occurrence. Nationally, 13.76% of the 21,079 wastewater samples were positive for HAV RNA, and both concentrations and positivity rates were associated with NNDSS hepatitis A case data nationally (Kendall rank correlation coefficient = 0.20, concentrations; and 0.33, positivity rate; both < 0.05). We further demonstrated that higher rates of wastewater HAV detection were positively associated with socioeconomic indicators of vulnerability including homelessness and drug overdose deaths (both < 0.0001). Areas with above average levels of homelessness were 48% more likely to have HAV wastewater detections, while areas with above average levels of drug overdose deaths were 14% more likely to have HAV wastewater detections. Using more granular case data, we present a case study in the state of Maine that reinforces these results and suggests a potential lead time for wastewater over clinical case detection and exposure events. The ability to detect HAV RNA in wastewater before clinical cases emerge could allow public health officials to implement targeted interventions like vaccination campaigns.IMPORTANCEDespite the existence of a highly effective vaccine for hepatitis A, outbreaks in vulnerable populations remain common. The disease can be asymptomatic or subclinical, and disproportionately impacts populations with inadequate access to healthcare, leading to a severe underestimation of the occurrence of this viral infection. This study investigates the potential for wastewater measurements of biomarkers of the causative agent of hepatitis A (HAV RNA) to provide insights into disease occurrence. Results highlight the potential for wastewater-based epidemiology to be a complementary tool to traditional surveillance for monitoring and controlling HAV transmission.
基于污水的流行病学旨在通过测量污水中的传染病生物标志物来评估社区中疾病的发生情况,这可能是了解社区甲型肝炎感染发生情况的一种有价值的工具。在这项研究中,我们测量了来自美国 40 个州和哥伦比亚特区的 191 个污水处理厂的样本中甲型肝炎病毒 (HAV) RNA 的浓度,并将测量结果与传统的疾病发生测量方法进行了比较。在全国范围内,21079 个污水样本中有 13.76%检测到 HAV RNA,浓度和阳性率均与全国 NNDSS 甲型肝炎病例数据相关(肯德尔等级相关系数=0.20,浓度;0.33,阳性率;均<0.05)。我们还进一步证明,较高的污水 HAV 检测率与易受伤害的社会经济指标呈正相关,包括无家可归和药物过量死亡(均<0.0001)。无家可归率高于平均水平的地区进行 HAV 污水检测的可能性高出 48%,而药物过量死亡率高于平均水平的地区进行 HAV 污水检测的可能性高出 14%。使用更细粒度的病例数据,我们在缅因州进行了一项案例研究,强化了这些结果,并表明污水检测可能比临床病例检测和暴露事件具有潜在的提前期。在临床病例出现之前,能够在污水中检测到 HAV RNA,可能使公共卫生官员能够实施疫苗接种等有针对性的干预措施。
尽管存在高效的甲型肝炎疫苗,但弱势群体仍经常爆发该疾病。这种疾病可能是无症状或亚临床的,并且不成比例地影响到医疗保健服务不足的人群,导致对这种病毒感染的发生情况严重低估。本研究探讨了测量甲型肝炎病原体生物标志物(HAV RNA)的污水测量值是否可以提供对疾病发生情况的见解。研究结果强调了基于污水的流行病学作为传统监测工具的补充,用于监测和控制 HAV 传播的潜力。